Shares of Absci Co. (NASDAQ:ABSI – Get Free Report) have received a consensus recommendation of “Buy” from the seven brokerages that are covering the company, MarketBeat.com reports. Seven investment ...

Absci Corporation’s ABSI share price has surged by 17.57%, which has investors questioning if this is right time to sell.

As you can see from the chart above the percentage of shares that are sold short for Absci has grown since its last report. This does not mean that the stock is going to fall in the near-term but ...

The Stargate Project, a $500B initiative focused on artificial intelligence, lifts AI-driven biotech stocks and an unlikely winner, Metagenomi (MGX). Read more here.

In this article, we are going to take a look at where Absci Corporation (NASDAQ:ABSI) stands against the other medical AI ...

Simultaneously, ARK has been bolstering its stake in Absci Corp (NASDAQ:ABSI), with the ARKG ETF purchasing 20,310 shares worth $81,849. This buy is part of a recent trend, as ARK previously acquired ...

This approach allows Absci to quickly advance and monetize clinical-stage assets, aligning well with its AI/ML-driven platform. Price Action: ABSI stock is up 23% at $3.96 at the last check on ...